glp 1 kidney disease Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Recommendations for SGLT2i versus GLP-1

This raises potential concerns for patients with pancreatic and gastrointestinal neuroendocrine cancer or those with genetic conditions like multiple endocrine neoplasia syndrome (MEN1), which predispose individuals to NENs

Nitrate-Nitrite-Nitric Oxide Pathway

Reviewed against primary medical, regulatory, and trial sources for accuracy, sourcing, and patient-safety framing.

Medical experts recommend evidence-based approaches including caloric restriction, at least 150 minutes of weekly exercise, behavioral interventions, and dietary patterns like Mediterranean or DASH diets

Lee SH, Takahashi K, Hatakawa Y, Oe T